Neumora Therapeutics, Inc.
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
NMRA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6409791000
- LEI:
- Country:
- United States of America
- Address:
- 260 ARSENAL PLACE, SUITE 1, 2472 WATERTOWN
- Website:
- https://neumoratx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for brain diseases. The company aims to redefine neuroscience drug development by applying a data-driven approach to address unmet needs in neuropsychiatric and neurodegenerative disorders. Its core strategy utilizes a proprietary 'Precision Toolbox,' which integrates translational, clinical, and computational data to identify targeted patient populations and develop novel therapies. Neumora's pipeline consists of multiple programs pursuing novel mechanisms of action to discover and commercialize a new generation of treatments for Central Nervous System (CNS) diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Neumora Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neumora Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neumora Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
